Intelerad Medical Systems Appoints New President and CEO

Montreal, Quebec, September 25, 2018 – Intelerad Medical Systems™, a leader in enterprise workflow solutions, is pleased to announce that following the retirement of Randall Oka, its board of directors has appointed Paul Lepage as its new president and chief executive officer.

Paul Lepage is a seasoned executive with over 15 years of experience in healthcare IT. He has served as COO of Locus Dialog, as president and CEO of Medisolution (ERP) and most recently as president of TELUS Health and Payment Solutions.

Under his leadership, TELUS Health has become Canada’s leading provider of health IT solutions for providers, payers, and patients, and is well poised for the next stage of its growth. During his tenure, Mr. Lepage pioneered Telus into various new markets and led a number of strategic acquisitions. He holds a degree in engineering from Polytechnique Montréal, an MBA from Concordia University and an honorary doctorate from Université de Montréal.

“We are thankful for Randall Oka’s outstanding contribution to Intelerad during the last 18 years, he has been instrumental in building a strong foundation. With the ambitious goals that we have for Intelerad, we are thrilled to have Paul, a leader with such an impressive track record in healthcare technology, join as the new president and CEO of Intelerad. His experience and industry knowledge will be key to Intelerad’s continued success.” said Francois Laflamme, senior partner at Novacap and chairman of the board at Intelerad.

“Intelerad’s growth over the last decade has been strong and steady and we are grateful to have become the medical imaging software backbone for some of the largest imaging providers in the world, with millions of studies going through Intelerad systems. I am excited to join the dedicated team that is working on the next generation of cloud-based solutions, taking scalability, performance, and workflow efficiency to the next level and incorporating machine learning technologies and artificial intelligence into the field of diagnostic imaging. This is a great time to join Intelerad and help make a difference in healthcare. I am looking forward to meeting with Intelerad clients, staff, and business partners.” said Paul Lepage.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup